BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 904677)

  • 1. Prophylactic antibodies in Hodgkin's disease.
    Westphal R
    N Engl J Med; 1977 Oct; 297(17):948. PubMed ID: 904677
    [No Abstract]   [Full Text] [Related]  

  • 2. Circulating lymphoid cells in Hodgkin's disease.
    Fairley GH
    Natl Cancer Inst Monogr; 1973 May; 36():95-8. PubMed ID: 4270378
    [No Abstract]   [Full Text] [Related]  

  • 3. A micro-method for PHA-induced stimulation of human lymphocytes. II. communication: effect of splenectomy on the inhibitory activity of serum in patients with Hodgkin's disease.
    Pappas A; Pees H; Girmann G
    Z Immunitatsforsch Immunobiol; 1977 Apr; 153(1):1-10. PubMed ID: 868205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overwhelming post-splenectomy infection in Hodgkin's disease: pathogenesis and prevention.
    Shimm DS; Linggood RM; Weitzman SA
    Clin Radiol; 1983 Jan; 34(1):95-7. PubMed ID: 6822044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Discussion with reference to laparotomy and splenectomy in Hodgkin's disease].
    Teillet F; Bernard J
    Ann Med Interne (Paris); 1970 Mar; 121(3):283-4. PubMed ID: 5507502
    [No Abstract]   [Full Text] [Related]  

  • 6. [Long term effects of splenectomy on the immune-status of Hodgkin's disease patients depending on the modality of treatment (author's transl)].
    Schaadt M; Diehl V; Kalden JR; Schmidt N; Laskewitz E
    Med Klin; 1978 Oct; 73(40):1381-8. PubMed ID: 309061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Splenectomy in children with Hodgkin's disease].
    Armata J; Borkowski W
    Pol Tyg Lek; 1975 Sep; 30(37):1543-5. PubMed ID: 1099558
    [No Abstract]   [Full Text] [Related]  

  • 8. The potential benefits of therapeutic splenectomy for patients with Hodgkin's disease and non-Hodgkin's lymphomas.
    Schreiber DP; Jacobs C; Rosenberg SA; Cox RS; Hoppe RT
    Int J Radiat Oncol Biol Phys; 1985 Jan; 11(1):31-6. PubMed ID: 3838166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hodgkin's disease: considerable progress and more to be achieved.
    Mathé G; Tubiana M
    Ser Haematol; 1973; 6(2):244-69. PubMed ID: 4361523
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Second malignancies in treated Hodgkin's patients and splenectomy.
    Papaioannou A
    Lancet; 1975 Jun; 1(7920):1346-7. PubMed ID: 49550
    [No Abstract]   [Full Text] [Related]  

  • 11. Hodgkin's disease.
    DeVita VT
    Lancet; 1971 Jul; 2(7714):46-7. PubMed ID: 4103688
    [No Abstract]   [Full Text] [Related]  

  • 12. [Immunological status of patients with Hodgkin's disease after splenectomy].
    Glińska H; Turowski G; Radziszewska J
    Nowotwory; 1979; 29(2):93-104. PubMed ID: 314100
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation and treatment of Hodgkin's disease in the 70s.
    Einhorn LH
    J Indiana State Med Assoc; 1972 Apr; 65(4):303-6. PubMed ID: 5020964
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of radiochemotherapy and splenectomy on lymphoid subclasses in patients with Hodgkin's lymphoma in complete remission].
    Leoni P; Montroni M; Montillo M; Salvi A; Centurioni R; Fanciulli E
    G Clin Med; 1981 Oct; 62(10):685-92. PubMed ID: 6977469
    [No Abstract]   [Full Text] [Related]  

  • 15. Staging and treatment of Hodgkin's disease.
    Amiel JL; Droz JP
    Eur J Cancer (1965); 1978 Jan; 14(1):1-4. PubMed ID: 624298
    [No Abstract]   [Full Text] [Related]  

  • 16. Splenectomy in Hodgkin's disease: no therapeutic benefit.
    Newcomer LN; Cadman EC; Prosnitz LR; Farber LR; Bertino JR
    Am J Clin Oncol; 1982 Aug; 5(4):393-7. PubMed ID: 7113962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Choice of therapeutic methods during the 3d stage of Hodgkin's disease].
    Mazurowa A; Płuzańska A; Dmochowska M; Krykowski E; Fajndt S; Studencki E; Zadrozna O
    Pol Tyg Lek; 1978 Jul; 33(27):1073-5. PubMed ID: 693381
    [No Abstract]   [Full Text] [Related]  

  • 18. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
    Steele R; Han T
    Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changing therapeutic approaches to Hodgkin's disease.
    Prosnitz LR
    Prog Clin Cancer; 1973; 5():171-81. PubMed ID: 4571117
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of Hodgkin's disease at Villejuif from 1964 to 1974].
    Tubiana M; Mathé G
    Rev Prat; 1974 Oct; 24(45):3981-2, 3985-91. PubMed ID: 4445768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.